Carlsmed Inc is a commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CARL is expected to report earnings to rise 21.87% to -38 cents per share on August 27
Q2'26
Est.
$-0.39
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.03
The last earnings report on May 05 showed earnings per share of -31 cents, beating the estimate of -37 cents. With 61.49K shares outstanding, the current market capitalization sits at 267.77M.